naphazoline + pheniramine + panthenol

A fixed-dose combination of the sympathomimetic vasoconstrictor **naphazoline**, the first-generation antihistamine **pheniramine**, and the vitamin B5 analog **panthenol**. - **Naphazoline** acts as an alpha-adrenergic agonist that induces vasoconstriction, thereby reducing discomfort and redness in the nasal mucosa or conjunctival tissues. - **Pheniramine** blocks histamine H1-receptors, reducing allergy-mediated symptoms like itching and swelling. - **Panthenol** (provitamin B5) provides moisturizing and reparative effects on the mucosal surfaces and is intended to alleviate irritation and support healing. Primary indications include symptomatic relief of nasal congestion, allergic conditions of the nasal mucosa, and potentially for moisture support and irritation reduction in affected tissues. The combination has been studied in randomized clinical trials for the symptomatic control of nasal congestion, especially related to the common cold[2]. No unique branded product combining all three agents is documented in major drug databases, and this combination is likely regionally formulated or researched.